Skip to content

Investigator

Sai Ma

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · funded by NCI

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$937k

Summed across those awards.

First award
Mar 1, 2025

Latest Aug 8, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Characterizing DNA Methylation Dynamics in Trisomy 21-Associated Hematopoiesis and Leukemia

    $462k

    Aug 8, 2025NCIICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11129204 (opens the source filing in a new tab)

  2. R61

    High-throughput single-cell joint RNA and DNA methylation mapping of Acute Myeloid Leukemia

    $237k

    Mar 1, 2025NCIICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11062605 (opens the source filing in a new tab)

  3. R61

    High-throughput single-cell joint RNA and DNA methylation mapping of Acute Myeloid Leukemia

    $237k

    Mar 1, 2025NCIICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11290853 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources